Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

Logo
DHR US​

Danaher Corp /DE/(DHR US)

$230.50+0.750.33%Ext:$226.00-4.501.95%(Market Closed · 00:00:02 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings

Danaher Corp /DE/ — Company Profile

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
Exchange
UN
CEO
Rainer Blair
Headquarters
Washington, DC, US
IPO Date
Dec 29, 1978
Employees
59,000
Website
www.danaher.com

Key Metrics

Price
$214.06
Market Cap
$150.48B
Revenue (TTM)
$5.95B
Net Income (TTM)
$1.03B
EPS (TTM)
1.45
P/E (TTM)
40.79
P/B (TTM)
2.84
Dividend Yield
78.83%
ROE (TTM)
1.94%
ROA (TTM)
1.23%
Operating Margin
22.58%
Beta
0.62

Dividends

Last Dividend
$0.40
Last Yield
0.79%

Summary

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Website
www.danaher.com
Location
Washington, DC, US
Phone202 828 0850
Employees59,000
CEORainer Blair
Sector
Information Technology
Industry
Electronic Equipment, Instruments & Components
IPO DateDec 29, 1978

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(3.7K)

Expand
  • 8-KResults of Operations and Financial Condition20 Oct
  • 10-QQ3ended 25 Sept 202620 Oct
  • 3Initial statement of beneficial ownership16 Oct
  • 3Initial statement of beneficial ownership16 Oct
  • 4Statement of changes in beneficial ownership14 Oct
  • 4Statement of changes in beneficial ownership14 Oct
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers13 Oct
  • 3Initial statement of beneficial ownership2 Oct
  • 3Initial statement of beneficial ownership2 Oct
  • 25-NSENotification of removal from listing30 Sep
  • 4Statement of changes in beneficial ownership24 Aug
  • 144Blair Rainer21 Aug
  • 4Statement of changes in beneficial ownership6 Aug
  • 4Statement of changes in beneficial ownership6 Aug
  • 4Statement of changes in beneficial ownership6 Aug
  • 4Statement of changes in beneficial ownership6 Aug
  • 4Statement of changes in beneficial ownership6 Aug
  • 4Statement of changes in beneficial ownership6 Aug
  • 4Statement of changes in beneficial ownership6 Aug
  • 4Statement of changes in beneficial ownership6 Aug

News

  • Danaher Corporation $DHR Shares Sold by Compass Wealth Management LLC23 Oct
  • Danaher Corporation $DHR Shares Newly Acquired by Cantor Fitzgerald Investment Advisors L.P.23 Oct
  • LH vs. DHR: Which Stock Is the Better Value Option?22 Oct
  • Danaher Q3 Recap: Decent Results, Still A Hold22 Oct
  • Why Danaher Stock Bounced Higher Today21 Oct
  • Danaher Corporation (DHR) Q3 2026 Earnings Call Transcript21 Oct
  • Danaher: 3 Key Takeaways for Long-Term Investors21 Oct
  • Danaher Corp (DHR) (Q3 2026) Earnings Call Highlights: Core Growth Accelerates to 5.5% Ex-Respiratory as EPS Guidance Rises21 Oct
  • Danaher Q3 Review: Interested To See What The New Management Will Bring21 Oct
  • DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line21 Oct
  • Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves21 Oct
  • Danaher Q3 Earnings Call Highlights21 Oct
  • Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say21 Oct
  • Danaher (DHR) Tops Q3 Earnings and Revenue Estimates21 Oct
  • Danaher Reports Third Quarter 2026 Results21 Oct
  • Danaher Corporation $DHR Stock Holdings Lowered by Louisbourg Investments Inc.21 Oct
  • Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call19 Oct
  • Danaher Corporation $DHR Stock Bought by SteelPeak Wealth LLC19 Oct
  • Danaher Corporation $DHR Stock: IFP Advisors Inc Increases Stake19 Oct
  • Danaher Corporation $DHR Shares Bought by Birch Hill Investment Advisors LLC18 Oct

Mentions in Filings

  • … London, United Kingdom. From 2019 to 2021, he served as Chief Financial Officer of Nobel Biocare Systems, a dental implant and restorative dentistry business of Envista Holdings Corporation, which was spun off from <strong>Danaher Corporation</strong> in September 2019. Prior to that, Mr. Rouy-Poirier held senior finance and leadership roles at Honeywell, primarily in its Aerospace division and also in its Homes and Building Technologies and Electronic Materials …
    WISeSat.Space Holdings Corp.Danaher Corp /DE/·20-F - ANNUAL REPORT FY 2026·FY26·7 Oct
  • … served as Senior Vice President and Chief Quality officer at Medtronic. Prior to joining Medtronic in 2023, Mr. Cundy served as VP Quality, Regulatory, & Clinical Affairs Diagnostics and Life Sciences Platforms at <strong>Danaher Corporation</strong> (NYSE: DHR) from October 2020 to January 2023, as VP RA/QA Diagnostics & Life Sciences Platforms at Danaher Corporation from November 2018 to October 2020, as VP RA/QA Life Sciences Platform at Danaher Corporation f …
    MiniMed Group, Inc.Danaher Corp /DE/·424B3 - Prospectus filing (Rule 424(b)(3))·Q4 26·5 Oct
  • … ichael Betz, Scott Liles 2024: Robert J. Phelan, Douglas G. Beck, Michael Betz, Maurice Herrera 2023: Robert J. Phelan, Douglas G. Beck, Maurice Herrera, and Steven Tom 2022: Robert J. Phelan, Douglas G. Beck, John W. <strong>Danaher</strong>, and Maurice Herrera (2) The following tables show amounts deducted from and added to the SCT total to calculate CAP. The fair value of the equity awards was determined consistent with the methodology used to determine …
    Covista Inc.Danaher Corp /DE/·ARS - Annual report to security holders·FY26·2 Oct
  • … sified Industrial Segment products. We have comprehensive motion and control technologies allowing us to provide the broadest systems capabilities. While our primary global competitors include Bosch Rexroth AG, Copeland, <strong>Danaher</strong> Corporation, Danfoss A/S, Donaldson Company, Inc., Emerson/ASCO, Festo SE & Co., Freudenberg-NOK, Gates Corporation, IMI/Norgren, SMC Corporation, Swagelok Company, and Trelleborg AB, none of these businesses compete with …
    Parker-Hannifin CorpDanaher Corp /DE/·ARS - Annual report to security holders·FY26·18 Sep
  • … lic listing. Prior to December 2016, Mr. Niederpruem worked at Emerson Network Power as Vice President of Global Marketing and General Manager of Integrated Solutions and Vice President of Product Management and at <strong>Danaher Corporation</strong> as Director of Global Product Management, Engineering and Sales. Mr. Niederpruem holds a bachelor’s degree in marketing and logistics from John Carroll University and a master’s degree in business administration fro …
    Forgent Power Solutions, Inc.Danaher Corp /DE/·10-K - Annual report FY 2026·FY26·15 Sep
  • … ior Vice President and Treasurer (2009-2013) •  Various positions of increasing authority (1994-2009) | Microsoft Committees: •  Audit and Finance •  Governance and Nominating Other Public Company Directorships: •  <strong>Danaher Corporation</strong> •  lululemon athletica inc. •  Visa Inc. Former Public Company Directorships Heldin the Past Five Years: •  DoubleVerify Holdings, Inc. •  Oscar Health, Inc. Other Positions: •  Former Trustee, Financial Accounting …
    MICROSOFT CORPDanaher Corp /DE/·DEF 14A - Definitive proxy statement·Q2 27·21 Oct

Key Stats

Trading

Px/Chg 1D$214.06 / +1.09%
Avg Volume4.39M
Beta0.62
Mkt Cap150.48B
FD Mkt Cap150.14B

Float

Shrs Out/Float702.99M / 625.84M
Short Float0.02%
Days to Cover2.39
Stock Repurchased$9.00M

Current Valuation

EV163.27B
EV/EBITDA24.57
EV/Sales6.59
P/B2.84
P/S6.07
FCF Yield0.72%
ROE1.94%
ROA1.23%
Current Ratio1.87

Dividend

Cash$0.40
Yield78.83%
Yield (TTM)78.83%

Estimates

P/E40.79
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgApr '23Apr '24Apr '25Apr '26Oct '26
PRICE-BASED RATIOS
Price / Earnings71.4322.6836.5034.68115.52147.78
Price / Sales12.976.147.285.6620.2225.55
Price / Book Value2.953.263.252.732.632.87
Price / Free Cash Flow59.4322.1930.0825.5379.20140.15
ENTERPRISE VALUE METRICS
Enterprise Value166,910.5179,778.0187,548.9150,280.8152,087.2164,857.4
Enterprise Value / Sales14.176.757.856.2922.2427.70
Enterprise Value / EBITDA49.8718.9525.0120.6574.15110.57
Enterprise Value / EBIT64.7324.4535.1730.52106.50127.01

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue-4.4%29,453.026,643.023,890.023,875.024,568.0
Gross Income-4.4%17,952.016,188.014,034.014,206.014,970.0
EBITDA-8.7%10,007.09,485.07,499.07,276.06,945.0
EBIT-13%7,839.07,353.05,333.04,924.04,498.0
Net Income-13.4%6,433.07,209.04,764.03,899.03,614.0
EPS (Diluted)-12.5%8.619.646.385.295.04
BALANCE SHEET
Cash & ST Inv15.6%2,586.05,995.05,864.02,078.04,615.0
Total Assets8.4%83,184.084,350.084,488.077,542.083,464.0
Total Liabilities-5%38,007.034,260.030,998.027,992.030,930.0
Total Shareholder Equity3.8%45,167.050,082.053,486.049,543.052,534.0
CASH FLOW
Net Operating Cash Flow-6.4%8,358.08,519.07,164.06,688.06,416.0
Cap Ex-2.8%-1,294.0-1,152.0-1,383.0-1,392.0-1,156.0
Free Cash Flow-7.1%7,064.07,367.05,781.05,296.05,260.0

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)229.19
Basic Shares702.99
Market Cap161,117.4
Diluted Shares706.80
Fully Diluted Shares Outstanding706.80
Fully Diluted Market Cap161,991.5
+Consolidated Debt26,482.0
−In-the-Money Convertible Debt—
+Capital Leases-
+Operating Leases—
−Cash & Equivalents-5,682.0
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest12.0
+Pension Liabilities—
Enterprise Value181,929.4

Segment data

Revenue

by Products and services

  • Revenue From Contract With Customer, Measurement, Recurring82%
  • Revenue From Contract With Customer, Measurement, Nonrecurring18%

Revenue

by Geography

  • Other Developed Markets82%
  • China18%

Related companies

Teradyne, Inc

TER US

Keysight Technologies Inc.

KEYS US

Ametek Inc/

AME US

Compagnie De Saint Gobain

CODYY US

Roper Technologies Inc

ROP US

UltraTech Cement Ltd

UTCEM IB

China Jushi Co., Ltd.

600176 CG

Veralto Corp

VLTO US

Kingspan Group plc

KGSPY US

Mks Inc

MKSI US

Fortive Corp

FTV US

Toromont Industries Ltd./ADR

TMTNF US

Financials & Metrics

FinancialsChartingShort InterestEmployees